← Core Scientific, Inc./tx CORZ
Market Price
$20.16
Market Cap
$6.29B
P/E Ratio
N/A
Revenue (FY 2025)
↑760.6% YoY
$319.02M
3-Yr CAGR: 9.6%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↓-765.7% YoY
-$450.75M
FCF Yield: -7.17%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CORZ)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2020 | $54.2M | — | $9.4M | — | — | — | — | $-23.8M | $-23.8M | — |
| FY 2021 | $327.6M | +504.4% | $21.9M | — | — | — | — | $-1.9M | $-1.9M | +92.1% |
| FY 2022 | $242.5M | -26.0% | $8.4M | — | — | — | — | $205.2M | $-178.8M | -9,453.7% |
| FY 2023 | $86.2M | -64.4% | $123.5M | — | — | — | — | $65.1M | $49.0M | +127.4% |
| FY 2024 | $37.1M | -57.0% | $121.1M | — | — | — | — | $42.9M | $-52.1M | -206.4% |
| FY 2025 | $319.0M | +760.6% | $37.9M | — | — | — | — | $278.2M | $-450.8M | -765.7% |
Valuation
Market Price
$20.16
Market Cap
$6.29B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
N/A
FCF Yield
-7.17%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
11.88%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.14x
Revenue 3-Yr CAGR
9.57%
Financial Health & Liquidity
Current Ratio
22.95
Cash Ratio
19.74
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$311.38M
Total Debt
N/A
Book Value / Share
N/A
Cash Flow Efficiency
Operating Cash Flow
$278.25M
Capital Expenditures (CapEx)
$729.00M
Free Cash Flow
-$450.75M
OCF / Revenue
87.22%
FCF / Revenue
-141.29%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
N/A
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$2.35B
Total Liabilities
$2.35B
Stockholders' Equity
N/A
Current Assets
$362.16M
Current Liabilities
$15.78M